Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Hookipa Pharma Inc (HOOK)
NASDAQ:HOOK
Hookipa Pharma (HOOK) Stock Price & Analysis
301 Followers
HOOK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.68 - $2.05
Previous Close$1.31
Volume7.97M
Average Volume (3M)898.58K
Market Cap
$62.13M
Enterprise Value-$27.78M
Total Cash (Recent Filing)$109.60M
Total Debt (Recent Filing)$5.76M
Price to Earnings (P/E)-1.3
Beta0.79
Next Earnings
Aug 16, 2023EPS Estimate
-$0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding54,722,339
10 Day Avg. Volume1,343,284
30 Day Avg. Volume898,579
Standard Deviation0.21
R-Squared0.05
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.05
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.74
Enterprise Value/Gross Profit-1.95
Enterprise Value/Ebitda0.40
Forecast
1Y Price Target
$5.17Price Target Upside383.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Hookipa Pharma News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HOOK FAQ
What was Hookipa Pharma Inc’s price range in the past 12 months?
Hookipa Pharma Inc lowest stock price was $0.68 and its highest was $2.05 in the past 12 months.
What is Hookipa Pharma Inc’s market cap?
Currently, no data Available
When is Hookipa Pharma Inc’s upcoming earnings report date?
Hookipa Pharma Inc’s upcoming earnings report date is Aug 16, 2023 which is in 76 days.
How were Hookipa Pharma Inc’s earnings last quarter?
Hookipa Pharma Inc released its earnings results on May 11, 2023. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.226 by -$0.044.
Is Hookipa Pharma Inc overvalued?
According to Wall Street analysts Hookipa Pharma Inc’s price is currently Undervalued.
Does Hookipa Pharma Inc pay dividends?
Hookipa Pharma Inc does not currently pay dividends.
What is Hookipa Pharma Inc’s EPS estimate?
Hookipa Pharma Inc’s EPS estimate is -$0.25.
How many shares outstanding does Hookipa Pharma Inc have?
Hookipa Pharma Inc has 52,322,823 shares outstanding.
What happened to Hookipa Pharma Inc’s price movement after its last earnings report?
Hookipa Pharma Inc reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.226. Following the earnings report the stock price went up 1.075%.
Which hedge fund is a major shareholder of Hookipa Pharma Inc?
Among the largest hedge funds holding Hookipa Pharma Inc’s share is Baker Bros Advisors LP. It holds Hookipa Pharma Inc’s shares valued at 3M.
---
Hookipa Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.17 (383.18% Upside)
$5.17 (383.18% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 9.8%
Last 30 Days ▲ 9.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.83%
12-Months-Change
Fundamentals
Return on Equity
-57.58%
Trailing 12-Months
Asset Growth
-16.67%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Hookipa Pharma Inc
HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.
---
Top 5 ETFs holding HOOK
iShares Core S&P Total U.S. Stock Market ETF
$14.03K
Up to five ETFs with an Outperform Smart Score that hold HOOK. The ETFs are listed according to market value of HOOK within the ETF
---
Adverum Biotechnologies
―
Crispr Therapeutics AG
―
Editas Medicine
―
G1 Therapeutics
―
---